Eisai
4523.T
$40.00
Share price
-0.30%
Change (1 day)
-29.73%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
EPS for Eisai (4523.T)
EPS in 2023 (TTM): $2.18
According to Eisai's latest financial reports the company's current EPS (TTM) is $2.18. In 2022 the company made an earnings per share (EPS) of $1.60 a decrease over its 2021 EPS that were of $7.11.
EPS history for Eisai from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $2.18 | 36.22% |
| 2022 | $1.60 | -77.48% |
| 2021 | $7.11 | -41.88% |
| 2020 | $12.24 | -0.94% |
| 2019 | $12.36 | 52.59% |
| 2018 | $8.10 | 124.17% |
| 2017 | $3.61 | -49.42% |
| 2016 | $7.14 | 37.08% |
| 2015 | $5.21 | -11.75% |
| 2014 | $5.90 | -3.23% |
| 2013 | $6.10 | -18.56% |
| 2012 | $7.49 | -15.51% |
| 2011 | $8.87 | -3.75% |
| 2010 | $9.21 | -1.36% |
| 2009 | $9.34 |